16:41 EST TriSalus Life Sciences (TLSI) files $150M mixed securities shelf
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TLSI:
- TriSalus Life Sciences reports Q3 EPS (96c) vs (12c) last year
- TriSalus Life Sciences: Expanding Market Opportunities and Innovative Technology Justify Buy Rating
- Is TLSI a Buy, Before Earnings?
- TriSalus Life Sciences: Strategic Positioning and Product Pipeline Drive Buy Rating Amid Long-Term Growth Potential